Shedding of Ebola Virus Surface Glycoprotein Is a Mechanism of Self-regulation of Cellular Cytotoxicity and Has a Direct Effect on Virus Infectivity

Journal of Infectious Diseases

Volumn 212, Issue , 2015, Pages S322-S328

  Dolnik, Olga ^a,b   Volchkova, Valentina A ^a   Escudero Perez, Beatriz ^a   Lawrence, Philip ^a   Klenk, Hans Dieter ^b   Volchkov, Viktor E ^a  

^a CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

cytotoxicity; Ebola; Ebolavirus; glycoprotein GP; infectivity; shed GP; shedding

Indexed keywords

GLYCOPROTEIN; MEMBRANE PROTEIN; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; AUTOREGULATION; CELL SURFACE; CONTROLLED STUDY; CYTOTOXICITY; EBOLAVIRUS; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN FUNCTION; VIRAL GENETICS; VIRION; VIROGENESIS; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS RECOMBINANT; VIRUS RELEASE; VIRUS REPLICATION; VIRUS SHEDDING; ANIMAL; CELL LINE; CHLOROCEBUS AETHIOPS; EBOLA HEMORRHAGIC FEVER; GENETICS; METABOLISM; PATHOGENICITY; VERO CELL LINE; VIROLOGY; VIRULENCE; VIRUS ENTRY;

AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; MEMBRANE GLYCOPROTEINS; VERO CELLS; VIRAL PROTEINS; VIRION; VIRULENCE; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84943327908     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv268     Document Type: Article

References (24)

1. Kuhn JH, Bao Y, Bavari S, et al. Virus nomenclature below the species level: A standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Arch Virol 2013; 158:301-11.
2. Feldmann H, Sanchez A, Geisbert TW. Filoviridae: Marburg and Ebola viruses. In: Knipe DM, Howley PM, eds. Fields virology. Philadelphia: Lippincott Williams and Wilkins, 2013:923-56.
3. Chan SY, Speck RF, Ma MC, Goldsmith MA. Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J Virol 2000; 74:4933-7.
4. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 2005; 308:1643-5.
5. Ito H,Watanabe S, Sanchez A, Whitt MA, Kawaoka Y. Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J Virol 1999; 73:8907-12.
6. Yang Z, Delgado R, Xu L, et al. Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science 1998; 279:1034-7.
7. Volchkov VE, Feldmann H, Volchkova VA, Klenk HD. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A 1998; 95:5762-7.
8. Volchkov VE, Becker S, Volchkova VA, et al. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology 1995; 214:421-30.
9. Sanchez A, Trappier SG, Mahy BW, Peters CJ, Nichol ST. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A 1996; 93:3602-7.
10. Volchkova VA, Vorac J, Repiquet-Paire L, Lawrence P, Volchkov VE. Ebola virus GP gene polyadenylation versus RNA editing. J Infect Dis 2015; 212(suppl 2):S191-8.
11. Alazard-Dany N, Volchkova V, Reynard O, et al. Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level. J Gen Virol 2006; 87:1247-57.
12. Chan SY, Ma MC, Goldsmith MA. Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J Gen Virol 2000; 81:2155-9.
13. Francica JR, Matukonis MK, Bates P. Requirements for cell rounding and surface protein down-regulation by Ebola virus glycoprotein. Virology 2009; 383:237-47.
14. Simmons G,Wool-Lewis RJ, Baribaud F, Netter RC, Bates P. Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J Virol 2002; 76:2518-28.
15. Reynard O, Borowiak M, Volchkova VA, Delpeut S, Mateo M, Volchkov VE. Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins. J Virol 2009; 83:9596-601.
16. Volchkov VE, Volchkova VA, Muhlberger E, et al. Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science 2001; 291:1965-9.
17. Dolnik O, Volchkova V, Garten W, et al. Ectodomain shedding of the glycoprotein GP of Ebola virus. Embo J 2004; 23:2175-84.
18. Maruyama T, Rodriguez LL, Jahrling PB, et al. Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol 1999; 73:6024-30.
19. Rubins KH, Hensley LE,Wahl-Jensen V, et al. The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever. Genome Biol 2007; 8:R174.
20. Escudero-Perez B, Volchkova VA, Dolnik O, Lawrence P, Volchkov VE. Shed GP of Ebola virus triggers immune activation and increased vascular permeability. PLoS Pathog 2014; 10:e1004509.
21. Mateo M, Carbonnelle C, Reynard O, et al. VP24 is a molecular determinant of Ebola virus virulence in guinea pigs. J Infect Dis 2011; 204(suppl 3):S1011-20.
22. Hierholzer JC, Killington RA. Virus isolation and quantitation. In: Mahy BWJ, Kangro HO, eds. Virology methods manual. London: Academic Press Limited, 1996:25-46.
23. Volchkova VA, Dolnik O, Martinez MJ, Reynard O, Volchkov VE. Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs. J Infect Dis 2011; 204(suppl 3):S941-6.
24. Mohan GS, Ye L, LiW, et al. Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivity. J Virol 2015; 89:1205-17.